Key result
Acid-treated random donor platelets were investigated as a treatment strategy for alloimmunized thrombocytopenic patients.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Acid-treated platelets should not yet alter management of alloimmunized thrombocytopenia; leaves open clinical utility pending controlled studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sivakumaran et al. (1992) studied this question. Acid-treated random donor platelets were investigated as a treatment strategy for alloimmunized thrombocytopenic patients.
Synapse has enriched 10 related papers. Consider them for comparative context: